Document is current

Article History

Received: 5 January 2021

Accepted: 22 July 2021

First Online: 2 October 2021

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: Anna Yudina is an employee of Terumo BCT (Belgium) and holds shares in Terumo BCT. Saiju Jacob reports advisory board remunerations from Alexion Pharmaceuticals, Alnylam Pharmaceuticals and ArgenX Ltds, and speaker/chairman fees from Eisai Ltd, UCB Pharma and Terumo BCT. This includes speaker fees received for the 2018 Midlands Neurological Society meeting on PLEX in refractory neurology, which is the basis of this article. Gordon Mazibrada reports advisory board consultancy honoraria, international meeting sponsorship and MS research and service development donations from Biogen, Genzyme, Novartis, Merck-Serono, Roche and Teva. This includes speaker fees received for the 2018 Midlands Neurological Society meeting on PLEX in refractory neurology, which is the basis of this article. Sarosh Irani reports grants, personal fees and non-financial support from UCB, personal fees from Roivant, personal fees and non-financial support from MedImmun, during the conduct of the study; personal fees from ADCT, grants from ONO, grants from CSL Behring, outside the submitted work; In addition, Sarosh Irani has a patent VGKC / LGI1/ CASPR2 antibodies with royalties. Anu Jacob reports honoraria and speaker fees from Terumo BCT for talks related to plasma exchange. Anu Jacob is lead for the UK NHS NMO service (2010-2020).